3290: Coros Pace 3 vs. Apple Watch Review, Dostarlimab and Endometrial & Colorectal Cancer Research

February 7, 2025

3290: Coros Pace 3 vs. Apple Watch Review, Dostarlimab and Endometrial & Colorectal Cancer Research

February 7, 2025

FR: Coros Pace 3 vs. Apple Watch Review, Dostarlimab and Endometrial & Colorectal Cancer Research

Welcome back to today’s Friday Review where I’ll be breaking down the best of the week!

I’ll be sharing specifics on these topics:

– Weekly Podcast Recap
– Coros Pace 3 vs. Apple Watch (product review)
– Dostarlimab and Endometrial & Colorectal Cancer (research)

For all the details tune in to today’s Cabral Concept 3290 – Enjoy the show and let me know what you thought!

Show Highlights & Big Takeaways

1. Coros Pace 3 vs. Apple Watch

The Coros watch is an excellent choice for athletes due to its superior accuracy, ability to program custom workouts, and easy-to-use sprint interval training features that guide you through runs, sprints, and recovery periods. Unlike the Apple Watch, it excels in both indoor and outdoor running, providing the most precise data to enhance performance.

2. What is Dostarlimab

Dostarlimab is an immunotherapy drug that works as an immune checkpoint inhibitor by blocking the PD-1 protein, preventing cancer cells from suppressing the immune response. This helps the immune system recognize and destroy cancer cells more effectively.

3. What Does the Research Say About Dostarlimab

Studies indicate that dostarlimab is highly effective in treating endometrial and colorectal cancer, especially in patients with mismatch repair-deficient (dMMR) tumors. In one study, 100% of patients with dMMR endometrial cancer experienced complete tumor disappearance after six months of treatment.